CompletedNCT05340504
N-acetylcysteine compared with placebo in bipolarity
About this title
Evaluating the Hypothesized Mechanism of Action of N-acetylcysteine for Bipolar Disorder
Read the official source — NCT05340504Medication studyAges 18–60United States
Understand this study
Who was this study for?
Listed age limits: 18 years to 60 years.
- Listed locations
- CharlestonSee all locations and recruitment
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
Study information
Study start dateStarted: May 13, 2022
- Recruitment status
- Completed
- Enrollment listed in the registry
- 12
- Sponsor
- Medical University of South Carolina
- Sponsor type
- University
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
- Locations
- United States
- Age range
- From 18 Years to 60 Years
- Official registry ID
- NCT05340504
- Official title
Show the full official title
Experimentally Evaluating the Hypothesized Mechanism of Action of N-acetylcysteine for Bipolar Disorder
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Charleston
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Medical University of South Carolina, a university.
Did this study involve medication?
Yes. The study involved medication, including N-Acetyl cysteine and Placebo.
Who was this study for?
Listed age limits: 18 years to 60 years.
